GRACEcast 公開
[search 0]
もっと

Download the App!

show episodes
 
G
GRACEcast

1
GRACEcast

Howard (Jack) West, MD

Unsubscribe
Unsubscribe
月ごとの
 
Expert oncologists provide brief, distilled summaries of the most central issues in cancer management and emerging approaches for patients and caregivers. The Global Resource for Advancing Cancer Education (GRACE) is committed to providing the knowledge that will help enable the general public to be informed participants in their own care. Visit CancerGRACE.org for more info.
 
Loading …
show series
 
Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab in patients with squamous lung cancer. Though it achieved a statistical increase in OS, he does not consider it clinically relevant.cancerGRACE - H. Jack West, MD による
 
The REVEL trial studied 1,200 non-small cell lung cancer patients to see if the drug Cyramza (ramucirumab) improved overall surival. The doctors had mixed feelings about the results.cancerGRACE - H. Jack West, MD による
 
The doctors discuss the new FDA-approved drug for ALK positive lung cancer patients, Zykadia (ceritinib), including the dosage level, potential side effects and the ability of Zykadia to impact brain metastases.cancerGRACE - H. Jack West, MD による
 
Loading …

クイックリファレンスガイド

Google login Twitter login Classic login